Sirolimus Eluting Coronary Stent System

  • Biomime
  • Biomime
  • 0.1%

    Low ST Rate

  • 2.4%


  • 1700

    Patients Studied


BioMimeTM is a Sirolimus Eluting Coronary Stent System with an ultra-thin (65 µm) strut thickness.

This next generation (SES) has a Novel Hybrid Design with closed cells (on both ends of the stent) & open cells (in the middle)- this allows for Morphology Mediated Expansion for adequate conformability and lesser edge dissections.

BioPoly-Biodegradable Polymer: 2µm low thickness, stable and elastic polymer.

Stent design with non-linear S links & Y connectors allowing high flexibility and adequate side branch access. Strut width variability ensures optimal radial strength.

Low balloon over hang of less than 0.5mm to minimize healthy vessel injury.

Available in more than 94 Countries worldwide with more than 500,000 stents deployed.

meriT Trials: Consistent data in more than 1,700 patients upto 5 years follow-up.

Non Inferiority to XIENCE DES proven in meriT-V: published in Eurointervention (Sep'18)

Biomime CV - Sirolimus Eluting Coronary Stent System


  • 01

    Ultra-thin 65 µm strut thickness & Biodegradable Polymer-Based DES for Faster Healing.

  • 02

    Strut Width Variability for Optimal Radial Strength & Conformability.

  • 03

    Morphology Mediated Expansion for Lesser Edge Dissections .

  • 04

    Novel Hybrid Cell Design with Open Cells in the Middle for Adequate Side Branch Access

Product Specifications

Stent material Cobalt Chromium L605
Stent Strut thickness 65 µm
Stent architecture Hybrid Cell Design with Non-Linear links
Drug Sirolimus
Polymer PLLA and PLGA (Biodegradable + Biocompatible)
Delivery system Rapid Exchange
Drug Dose 1.25μg/mm2


Size Chart

Diameter/Length 8 mm 13 mm 16 mm 19 mm 24 mm 29 mm 32 mm 37 mm 40 mm 44 mm 48 mm
2 mm - BIO20013 BIO20016 BIO20019 BIO20024 - - - - - -
2.25 mm BIO22508 BIO22513 BIO22516 BIO22519 BIO22524 BIO22529 BIO22532 BIO22537 BIO22540 - -
2.5 mm BIO25008 BIO25013 BIO25016 BIO25019 BIO25024 BIO25029 BIO25032 BIO25037 BIO25040 BIO25044 BIO25048
2.75 mm BIO27508 BIO27513 BIO27516 BIO27519 BIO27524 BIO27529 BIO27532 BIO27537 BIO27540 BIO27544 BIO27548
3 mm BIO3008 BIO30013 BIO30016 BIO30019 BIO30024 BIO30029 BIO30032 BIO30037 BIO30040 BIO30044 BIO30048
3.5 mm BIO35008 BIO35013 BIO35016 BIO35019 BIO35024 BIO35029 BIO35032 BIO35037 BIO35040 BIO35044 BIO35048
4 mm BIO40008 BIO40013 BIO40016 BIO40019 BIO40024 BIO40029 BIO40032 BIO40037 BIO40040 - -
4.5 mm BIO45008 BIO45013 BIO45016 BIO45019 BIO45024 BIO45029 BIO45032 BIO45037 BIO45040 - -

Clinical Data

Study Name Type of Study Total Patients Status LINKS
Sponsor Initiated Studies
meriT-1 Study First-in-man 30 Completed Know more
meriT-2 Study Observational study 250 Completed Know more
meriT-3 Study Observational study 1161 Completed Know more
meriT-V Study Randomized controlled trial 256 Ongoing Know more
MILES-UK Registry UK based Registry 750 Ongoing Know more
MILES Global Registry Global Registry 600 Ongoing Know more